Skip to main content
Erschienen in: The European Journal of Health Economics 7/2018

26.12.2017 | Original Paper

Threshold analysis in the presence of both the diagnostic and the therapeutic risk

verfasst von: Stefan Felder, Thomas Mayrhofer

Erschienen in: The European Journal of Health Economics | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

The well-established a priori probability of illness threshold in medical decision making, introduced by Pauker and Kassirer (N Engl J Med 293:229–234, 1975; N Engl J Med 302:1109–1117, 1980), involves the diagnostic risk only. We generalize the threshold analysis by adding the therapeutic risk, i.e., in accounting for the risk that a treatment might sometimes fail. We derive a priori probability of illness threshold as a function of the probability of successful treatment, as well as the inverted function, where the successful treatment probability threshold is a function of the a priori probability of illness. The thresholds in the general model are higher than those in the special cases where one of the two risks is absent. Applications show that the changes in the thresholds can be substantial. Our general model might explain empirical findings of much higher thresholds than the Pauker–Kassirer model suggests.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
For example, if health is measured in remaining life years and a successful treatment will lead to 10 remaining life years, no treatment to 7 remaining life years and unsuccessful treatment to 6 remaining life years, \(s_{d} = u\left( {10} \right) - u\left( 7 \right) > 0\) and \(f_{\text{d}} = u\left( 7 \right) - u\left( 6 \right) > 0\).
 
Literatur
1.
Zurück zum Zitat Pauker, S.G., Kassirer, J.P.: Therapeutic decision making: a cost-benefit analysis. N. Engl. J. Med. 293, 229–234 (1975)CrossRefPubMed Pauker, S.G., Kassirer, J.P.: Therapeutic decision making: a cost-benefit analysis. N. Engl. J. Med. 293, 229–234 (1975)CrossRefPubMed
2.
Zurück zum Zitat Pauker, S.G., Kassirer, J.P.: The threshold approach to clinical decision making. N. Engl. J. Med. 302, 1109–1117 (1980)CrossRefPubMed Pauker, S.G., Kassirer, J.P.: The threshold approach to clinical decision making. N. Engl. J. Med. 302, 1109–1117 (1980)CrossRefPubMed
4.
Zurück zum Zitat Eisenberg, J.M., Hershey, J.C.: Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med. Decis. Making 3, 155–168 (1983)CrossRefPubMed Eisenberg, J.M., Hershey, J.C.: Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med. Decis. Making 3, 155–168 (1983)CrossRefPubMed
5.
Zurück zum Zitat Young, M.J., Eisenberg, J.M., Williams, S.V., Hershey, J.C.: Comparing aggregate estimates of derived thresholds for clinical decisions. Health Serv. Res. 20, 763–780 (1986)PubMedPubMedCentral Young, M.J., Eisenberg, J.M., Williams, S.V., Hershey, J.C.: Comparing aggregate estimates of derived thresholds for clinical decisions. Health Serv. Res. 20, 763–780 (1986)PubMedPubMedCentral
6.
Zurück zum Zitat Basinga, P., Moreira, J., Bisoffi, Z., Bisig, B., Van den Ende, J.: Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda. Med. Decis. Making 27, 53–60 (2007)CrossRefPubMed Basinga, P., Moreira, J., Bisoffi, Z., Bisig, B., Van den Ende, J.: Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda. Med. Decis. Making 27, 53–60 (2007)CrossRefPubMed
7.
Zurück zum Zitat Sreeramareddy, C.T., Rahman, M., Harsha Kumar, H.N., et al.: Intuitive weights of harm for therapeutic decision making in smear-negative pulmonary tuberculosis: an interview study of physicians in India, Pakistan and Bangladesh. BMC Med. Inform. Decis. Making 14, 67 (2014)CrossRef Sreeramareddy, C.T., Rahman, M., Harsha Kumar, H.N., et al.: Intuitive weights of harm for therapeutic decision making in smear-negative pulmonary tuberculosis: an interview study of physicians in India, Pakistan and Bangladesh. BMC Med. Inform. Decis. Making 14, 67 (2014)CrossRef
8.
Zurück zum Zitat Hozo, I., Djulbegovic, B.: When is diagnostic testing inappropriate or irrational? Acceptable regret approach. Med Decis Making 28, 540–553 (2008)CrossRefPubMed Hozo, I., Djulbegovic, B.: When is diagnostic testing inappropriate or irrational? Acceptable regret approach. Med Decis Making 28, 540–553 (2008)CrossRefPubMed
9.
Zurück zum Zitat Roy, P.M., Colombet, I., Durieux, P., Chatellier, G., Sors, H., Meyer, G.: Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 331, 259 (2005)CrossRefPubMedPubMedCentral Roy, P.M., Colombet, I., Durieux, P., Chatellier, G., Sors, H., Meyer, G.: Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 331, 259 (2005)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hull, R.D.: Diagnosing pulmonary embolism with improved certainty and simplicity. JAMA 295, 213–215 (2006)CrossRefPubMed Hull, R.D.: Diagnosing pulmonary embolism with improved certainty and simplicity. JAMA 295, 213–215 (2006)CrossRefPubMed
11.
Zurück zum Zitat Haering, A., Heinrich, T., Mayrhofer T.: Exploring the consistency of higher-order risk preferences: Ruhr Economic Papers; 2017. Report No.: 3867887985 Haering, A., Heinrich, T., Mayrhofer T.: Exploring the consistency of higher-order risk preferences: Ruhr Economic Papers; 2017. Report No.: 3867887985
12.
Zurück zum Zitat Krieger, M., Mayrhofer, T.: Patient preferences and treatment thresholds under diagnostic risk. Ruhr Economic Papers No. 321, Essen, Germany (2012) Krieger, M., Mayrhofer, T.: Patient preferences and treatment thresholds under diagnostic risk. Ruhr Economic Papers No. 321, Essen, Germany (2012)
13.
Zurück zum Zitat Heinrich, T., Mayrhofer, T.: Higher-order risk preferences in social settings. Exp. Econ. 1–23 (2017) Heinrich, T., Mayrhofer, T.: Higher-order risk preferences in social settings. Exp. Econ. 1–23 (2017)
14.
Zurück zum Zitat Eeckhoudt, L.R., Lebrun, T.C., Sailly, J.C.: The informative content of diagnostic tests: an economic analysis. Soc. Sci. Med. 18, 873–880 (1984)CrossRefPubMed Eeckhoudt, L.R., Lebrun, T.C., Sailly, J.C.: The informative content of diagnostic tests: an economic analysis. Soc. Sci. Med. 18, 873–880 (1984)CrossRefPubMed
15.
Zurück zum Zitat Sox, H.C.: Medical decision making. American College of Physicians, Philadelphia (2007) Sox, H.C.: Medical decision making. American College of Physicians, Philadelphia (2007)
16.
Zurück zum Zitat Felder, S., Mayrhofer, T.: Risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Med. Decis. Making 34, 33–41 (2014)CrossRefPubMed Felder, S., Mayrhofer, T.: Risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Med. Decis. Making 34, 33–41 (2014)CrossRefPubMed
17.
Zurück zum Zitat Djulbegovic, B., van den Ende, J., Hamm, R.M., et al.: When is it rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation. Eur. J. Clin. Invest. 45, 485–493 (2015)CrossRefPubMed Djulbegovic, B., van den Ende, J., Hamm, R.M., et al.: When is it rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation. Eur. J. Clin. Invest. 45, 485–493 (2015)CrossRefPubMed
18.
Zurück zum Zitat Djulbegovic, B., Hozo, I., Schwartz, A., McMasters, K.M.: Acceptable regret in medical decision making. Med. Hypotheses 53, 253–259 (1999)CrossRefPubMed Djulbegovic, B., Hozo, I., Schwartz, A., McMasters, K.M.: Acceptable regret in medical decision making. Med. Hypotheses 53, 253–259 (1999)CrossRefPubMed
19.
Zurück zum Zitat Djulbegovic, B., Hozo, I., Beckstead, J., Tsalatsanis, A., Pauker, S.G.: Dual processing model of medical decision-making. BMC Med. Inform. Decis. Mak. 12, 94 (2012)CrossRefPubMedPubMedCentral Djulbegovic, B., Hozo, I., Beckstead, J., Tsalatsanis, A., Pauker, S.G.: Dual processing model of medical decision-making. BMC Med. Inform. Decis. Mak. 12, 94 (2012)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Mukherjee, K.: A dual system model of preferences under risk. Psychol. Rev. 117, 243–255 (2010)CrossRefPubMed Mukherjee, K.: A dual system model of preferences under risk. Psychol. Rev. 117, 243–255 (2010)CrossRefPubMed
21.
Zurück zum Zitat Wakker, P.P.: Lessons learned by (from?) an economist working in medical decision making. Med. Decis. Making. 28, 690–698 (2008)CrossRefPubMed Wakker, P.P.: Lessons learned by (from?) an economist working in medical decision making. Med. Decis. Making. 28, 690–698 (2008)CrossRefPubMed
23.
Zurück zum Zitat Eeckhoudt, L., Lebrun, T., Sailly, J.C.: Risk-aversion and physicians’ medical decision-making. J Health Econ 4, 273–281 (1985)CrossRefPubMed Eeckhoudt, L., Lebrun, T., Sailly, J.C.: Risk-aversion and physicians’ medical decision-making. J Health Econ 4, 273–281 (1985)CrossRefPubMed
24.
Zurück zum Zitat Courbage, C., Rey, B.: Decision thresholds and changes in risk for preventive treatment. Health Econ. 25, 111–124 (2016)CrossRefPubMed Courbage, C., Rey, B.: Decision thresholds and changes in risk for preventive treatment. Health Econ. 25, 111–124 (2016)CrossRefPubMed
25.
Zurück zum Zitat Krieger, M., Mayrhofer, T.: Prudence and prevention: an economic laboratory experiment. Appl. Econ. Lett. 24, 19–24 (2017)CrossRef Krieger, M., Mayrhofer, T.: Prudence and prevention: an economic laboratory experiment. Appl. Econ. Lett. 24, 19–24 (2017)CrossRef
26.
Zurück zum Zitat Courbage, C., Rey, B.: Prudence and optimal prevention for health risks. Health Econ. 15, 1323–1327 (2006)CrossRefPubMed Courbage, C., Rey, B.: Prudence and optimal prevention for health risks. Health Econ. 15, 1323–1327 (2006)CrossRefPubMed
27.
Zurück zum Zitat Eeckhoudt, L., Gollier, C.: The impact of prudence on optimal prevention. Econ. Theor. 26, 989–994 (2005)CrossRef Eeckhoudt, L., Gollier, C.: The impact of prudence on optimal prevention. Econ. Theor. 26, 989–994 (2005)CrossRef
28.
Zurück zum Zitat Berger, L., Bleichrodt, H., Eeckhoudt, L.: Treatment decisions under ambiguity. J. Health Econ. 32, 559–569 (2013)CrossRefPubMed Berger, L., Bleichrodt, H., Eeckhoudt, L.: Treatment decisions under ambiguity. J. Health Econ. 32, 559–569 (2013)CrossRefPubMed
Metadaten
Titel
Threshold analysis in the presence of both the diagnostic and the therapeutic risk
verfasst von
Stefan Felder
Thomas Mayrhofer
Publikationsdatum
26.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 7/2018
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-017-0951-1

Weitere Artikel der Ausgabe 7/2018

The European Journal of Health Economics 7/2018 Zur Ausgabe